Neuspera's Implantable Sacral Nerve Stimulation System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)
Public ClinicalTrials.gov record NCT04232696. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Study of Neuspera's Implantable Sacral Nerve Stimulation (SNS) System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Prospective, multi-center, single-arm, seamless phase-pivotal study conducted in participants diagnosed with UUI who have failed or could not tolerate more conservative treatment. The trial will be conducted in two phases. Objective of Phase I: To assess the utilization of the system during the Sacral Nerve Stimulation (SNS) trial period and to help inform the length of hours of daily stimulation to be used in Phase II of the trial. Objective of Phase II: To assess the safety and efficacy of the Neuspera SNS System at 6-months for the primary efficacy endpoint and at 12 months for secondary safety and efficacy endpoints.
Study identification
- NCT ID
- NCT04232696
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 331 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 12, 2019
- Primary completion
- Jul 16, 2024
- Completion
- Nov 30, 2026
- Last update posted
- Nov 2, 2025
2019 – 2026
United States locations
- U.S. sites
- 31
- U.S. states
- 20
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Genesis Healthcare Partners | Encinitas | California | 92024 | — |
| Kaiser Permanente, LAMC | Los Angeles | California | 90027 | — |
| Kaiser Permanente | San Diego | California | 92119 | — |
| Clinical Research Center of Florida | Pompano Beach | Florida | 33060 | — |
| Florida Urology Partners, LLC | Tampa | Florida | 33615 | — |
| Midtown Urology | Atlanta | Georgia | 95816 | — |
| Meridian Clinical Research | Savannah | Georgia | 31406 | — |
| Comprehensive Urologic Care | Lake Barrington | Illinois | 60010 | — |
| Women's Health Advantage | Fort Wayne | Indiana | 46825 | — |
| Indiana University School of Medicine | Indianapolis | Indiana | 46202 | — |
| University of Kansas Hospital | Kansas City | Kansas | 66103-2937 | — |
| UofL Health System (University of Louisville) | Louisville | Kentucky | 40202 | — |
| Ochsner Medical | New Orleans | Louisiana | 70121 | — |
| University of Michigan Health - West | Wyoming | Michigan | 49519 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Minnesota Urology | Woodbury | Minnesota | 55125 | — |
| Specialty Research of St. Louis | St Louis | Missouri | 63141 | — |
| Adult & Pediatric Urology P.C. | Omaha | Nebraska | 68114 | — |
| Weill Cornell Medical College | New York | New York | 10065 | — |
| Premier Medical Group | Poughkeepsie | New York | 12603 | — |
| Associated Medical Professionals of NY | Syracuse | New York | 13210 | — |
| MetroHealth | Cleveland | Ohio | 44109 | — |
| The Oregon Clinic Urogynecology West | Portland | Oregon | 97225 | — |
| The Institute for Female Pelvic Medicine and Reconstructive Surgery | North Wales | Pennsylvania | 19454 | — |
| Southern shores urogynecology | Myrtle Beach | South Carolina | 29572 | — |
| Southern Urogynecology | West Columbia | South Carolina | 29169 | — |
| Center for Pelvic Health | Franklin | Tennessee | 37067 | — |
| Urology Austin | Austin | Texas | 78745 | — |
| Urology Clinics of North Texas (Dallas Center for Pelvic Medicine) | Dallas | Texas | 75231 | — |
| Virginia Mason | Seattle | Washington | 98101 | — |
| University of Washington | Seattle | Washington | 98133 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04232696, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2025 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04232696 live on ClinicalTrials.gov.